Abstract:Peripheral nerve injury may lead to neuropathic pain and cause a markedly increase expression of growth associated protein-43 (GAP-43) in the spinal cord and dorsal root ganglion, local anesthetics blocking electrical impulse propagation of nerve fibers may also affect the expression of GAP-43 in the spinal cord and dorsal root ganglion. To determine the effects of continuous peripheral nerve block by tetrodotoxin before and after nerve injury on GAP-43 expression in the dorsal root ganglion during the development of neuropathic pain. A randomized controlled animal experiment. Department of Anesthesiology, the Second Hospital of Xiamen City; Department of Anesthesiology, the Second Affiliated Hospital of Shantou University Medical College. Thirty-five Sprague Dawley (SD) rats, weighing 200–250 g, were randomly divided into four groups control group (n =5), simple sciatic nerve transection group (n =10), peripheral nerve block before and after sciatic nerve transection groups (n =10). All the sciatic nerve transection groups were divided into two subgroups according to the different postoperative survival periods: 3 and 7 days (n =5) respectively. Mouse anti-GAP-43 monoclonal antibody (Sigma Co., Ltd.), supervision TM anti-mouse reagent (HRP, Changdao antibody diagnosis reagent Co., Ltd., Shanghai), and HMIAS-100 image analysis system (Qianping Image Engineering Company, Tongji Medical University) were employed in this study. This experiment was carried out in the Department of Surgery and Pathological Laboratory, the Second Affiliated Hospital of Shantou University Medical College from April 2005 to April 2006. The animals were anesthetized and the right sciatic nerve was exposed and transected at 1 cm distal to sciatic notch. Tetrodotoxin 10 μg/kg was injected percutaneously between the greater trochanter and the posterior superior iliac spine of right hind limb to block the sciatic nerve proximally at 1 hour before or 4 hours after nerve injury respectively, the injection was repeated in all the rats every 12 hours. At 3 or 7 days after nerve injury, immunohistochemistry and image analysis were used to evaluate the expression of GAP-43 in the dorsal root ganglions of L5 to the transected sciatic nerve, and quantitative analysis was also performed. Statistical analysis was performed using one way analysis of variance followed by t test. Expression of GAP-43 in the right dorsal root ganglions of L5. All the 35 SD rats were involved in the final analysis of results. In normal rats, there were very low expressions of GAP-43 in the dorsal root ganglions. In simple sciatic nerve transection rats 3 and 7 days after sciatic nerve transection, the average absorbance value of GAP-43 immunopositive neurons were significantly different from that in normal rats (t =8.806, 6.771, P < 0.01). Whereas 3 and 7 days after sciatic nerve transection in rats with peripheral nerve block before and after nerve injury, the average absorbance value of GAP-43 immunopositive neurons were not significantly different from that in normal rats (P > 0.05). Local anesthetic continuous peripheral nerve block before or after nerve injury can suppress nerve injury induced high expression of GAP-43 during the development of neuropathic pain.

Effect of Intrathecal Glial Cell Line-Derived Neurotrophic Factor on P38mapk Protein Expression in Spinal Dorsal Horn in a Rat Model of Neuropathic Pain

Effect of sciatic nerve pulsed radiofrequency glial activation levels in spinal dorsal horn in chronic constriction injury rat models and its analgesia effect

Effect of Glial Cell Line-Derived Neurotrophic Factor on Fos Protein Expression in the Spinal Dorsal Horn of Neuropathic Pain Rat Model

Effects of Ghrelin on Pgsk-3Β and Β-Catenin Expression when Protects Against Neuropathic Pain Behavior in Rats Challenged with Chronic Constriction Injury

Effect of intraperitoneal injection of Lidocaine on expression of NMDAR1 in spinal dorsal horn of a rat model of incisional pain

Effects of Glial Cell Line-Derived Neurotrophic Factor Intrathecal Injection on Spinal Dorsal Horn Glial Fibrillary Acidic Protein Expression in a Rat Model of Neuropathic Pain

EFFECT OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR ON RAT NEUROPATHIC PAIN

Pulsed Radiofrequency to the Dorsal Root Ganglion or the Sciatic Nerve Reduces Neuropathic Pain Behavior, Decreases Peripheral Pro-Inflammatory Cytokines and Spinal Β-Catenin in Chronic Constriction Injury Rats

EFFECTS OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR ON THE PRODUCT OF NO AND THE ACTIVITY OF NOS IN SPINAL CORD IN RATS MODEL OF NEUROPATHIC PAIN

Expression of glial cell line-derived neurotrophic factor in dorsal root ganglion in rats with chronic neuropathic pain

Delayed Inhibition of ERK and P38 Attenuates Neuropathic Pain Without Affecting Motor Function Recovery after Peripheral Nerve Injury.

Effects of Subcutaneous Transfection of Human Beta-Nerve Growth Factor Gene on Expression of Substance P in Dorsal Root Ganglion in a Rat Model of Diabetic Neuropathic Pain

Glial cell line-derived neurotrophic factor contributes to delayed inflammatory hyperalgesia in adjuvant rat pain model.

UPREGULATION OF THE BRAIN-DERIVED NEUROTROPHIC FACTOR IN THE SPINAL DORSAL HORN OF NEUROPATHIC RATS INDUCED BY SPINAL NERVE LIGATION

EXPRESSION OF NGF IN DORSAL HORN AND DORSAL ROOT GANGLION OF RATS WITH PACLITAXEL-EVOKED NEUROPATHIC PAIN

Temporal Changes of Spinal Transcriptomic Profiles in Mice With Spinal Nerve Ligation.

Effects of Intrathecal Morphine on Excitatory Amino Acid Contents of Spinal Cord in a Rat Model of Incision Pain

Effects of Subcutaneous Transfection of Human Beta-Nerve Growth Factor Gene on Function of Sensory Nerve in a Rat Model of Diabetic Neuropathic Pain

Effect of intrathecal injection of KN93 on pain behaviors in rats with neuropathic pain

The effect of intrathecal administration TRPA1 antagonists in a rat model of neuropathic pain.

Effects of Continuous Peripheral Nerve Block by Tetrodotoxin on Growth Associated Protein-43 Expression During Neuropathic Pain Development